MedTrace Logo

Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan

NCT02202694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-01-16

No results posted yet for this study

Summary

Aim:

To assess the feasibility of application of culturally-adapted CBT (CaCBTp) for use in Pakistan.

Design:

Randomized Control Trial

Setting:

Psychiatry Departments of General Hospitals in Karachi.

Participants:

A total of 36 patients with a diagnosis of psychotic disorder will be randomized to a psychological intervention or treatment as usual arm.

Intervention:

Culturally Adapted Cognitive Behavioral Therapy (CBT)

Outcome measure:

Positive and Negative syndrome scale (PANSS) Psychotic symptoms Rating Scales (PSYRATS)

Conditions

Interventions

BEHAVIORAL

Culturally Adapted Cognitive behavior therapy

This 12 session Multimodal Psychosocial Intervention will include a supportive component, an educational component, psychosocial component

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • Dow University of Health Sciences

    collaborator OTHER

  • Abbasi Shaheed Hospital

    collaborator OTHER

  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nusrat Husain, MD · Pakistan Institute of Learning and Living, University of Manchester

  • Imran Chaudhry, MD · University of Manchester

  • Farooq Naeem, MRCPsych · Pakistan Institute of Learning and Living, University of Southampton

  • Raza ur Rehman, FCPS · Dow University of Health Sciences

  • Ajmal Kazmi · Pakistan Institute of Living and Learning

  • Munir Hamirani, FCPS · Abbasi Shaheed Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02202694 on ClinicalTrials.gov